Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies-Reference-Cited by-同舟云学术

Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies

Published:2019-02 Issue:2-3 Volume:21 Page:
ISSN:1099-498X
Container-title:The Journal of Gene Medicine
language:en
Short-container-title:J Gene Med

Author:

Hamada Katsuyuki¹²^ORCID,Takagi Soichi³⁴,Kuboshima Hajime⁴,Shimada Hideaki⁵^ORCID,Takagi Kazuko²,Yasuoka Toshiaki²^ORCID,Matsubara Keiichi²^ORCID,Sassa Yukiko⁶,Furuya Tetsuya⁶,Suzuki Kazuhiko⁶,Uchide Tsuyoshi⁶^ORCID,Mizutani Tetsuya⁷,Tani Kenzaburo⁸^ORCID,Itoh Hiroshi⁹,Sugiyama Takashi²^ORCID

Affiliation:

1. Department of Clinical Oncology, School of Medicine Toho University Tokyo Japan

2. Department of Obstetrics and Gynecology, School of Medicine Ehime University Ehime Japan

3. Advanced Biomedical Engineering and Science, Graduate School of Medicine Tokyo Women's Medical University Tokyo Japan

4. Animal Stem Cell Inc. Tokyo Japan

5. Department of Surgery, School of Medicine Toho University Tokyo Japan

6. Cooperative Department of Veterinary Medicine, Faculty of Agriculture Tokyo University of Agriculture and Technology Tokyo Japan

7. Research and Education Center for Prevention of Global Infectious Disease of Animal, Faculty of Agriculture Tokyo University of Agriculture and Technology Tokyo Japan

8. Project Division of ALA Advanced Medical Research, The Institute of Medical Science The University of Tokyo Tokyo Japan

9. Animal Medical Center, Faculty of Agriculture Tokyo University of Agriculture and Technology Tokyo Japan

Publisher

Wiley

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgm.3064

Reference23 articles.

1. National Institute of Health Office of Science Policy Recombinant DNA Advisory Committee.Human gene transfer protocols. [Updated 15 September 2017.] Available from URL:https://osp.od.nih.gov/wp‐content/uploads/PROTOCOL_Sep2017_508.pdf

2. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

3. Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study

4. Cellular Immunity Delimits Adenoviral Gene Therapy Strategies for the Treatment of Neoplastic Diseases

5. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer cell-specific gene disruption of VEGF-A using Cas9;Personalized Medicine Universe;2023-11-30

2. Cancer treatment evolution from traditional methods to stem cells and gene therapy;Current Gene Therapy;2021-11-19

3. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review;Frontiers in Veterinary Science;2021-02-17

4. Oncolytic Viruses and the Immune System: The Dynamic Duo;Molecular Therapy - Methods & Clinical Development;2020-06